Research Links 12% of Global Cancer Cases to Preventable Infections

A new study published in The Lancet Oncology reveals that approximately 2.3 million new cancer cases worldwide in 2024, representing 12% of all diagnoses, are attributable to treatable or preventable infections. This highlights a significant opportunity to reduce the global cancer burden through existing interventions like vaccines, screening, and treatments for infections such as human papillomavirus (HPV) and H. pylori.